Advanced Molecular Diagnostics Testing

The contract titled Advanced Molecular Diagnostics Testing is a small business set-aside under the SBA Total Small Business Set-Aside provision, targeting providers capable of performing high-complexity molecular diagnostic testing using PCR and nucleic acid amplification techniques. It requires the performance of tests for infectious diseases and cancer-related genetic markers, demanding advanced technical expertise and compliance with stringent laboratory standards. The work is to be performed in Phoenix, Arizona, with a zip code of 85016, and is classified under NAICS code 541380 for Medical Diagnostic Laboratories. The opportunity is issued by the Phoenix Area Indian Health Service under the U.S. Department of Health and Human Services and is structured as a subcontract. The solicitation was posted on May 5, 2026, with a strict response deadline of May 11, 2026, at 8:00 PM Eastern Time. Only small businesses meeting the SBA’s size standards are eligible to compete, emphasizing the agency’s commitment to supporting small business participation in federal contracting. There is no specified point of contact listed in the data, and while the full office address is incomplete, performance is clearly anchored in Phoenix. Interested entities must prepare and submit responsive proposals before the deadline to be considered for award under this contract opportunity.